Read on Twitter
This morning on the @2020Network podcast, @jodilhbutts had a great conversation with @opensrcpharma about the need to shift the way that we do drug and vaccine development - toward open science, sharing of results, and global equitable access: https://pca.st/episode/71d508b7-5456-4307-a3d1-7a4a8fa89b85
Completely agree that now is the time to do drug and vaccine development differently, and Canada can lead the way on this. #COVID19 is an urgent call to change the way we do this, but the problem is bigger: https://ipolitics.ca/2020/06/10/world-must-rethink-drug-and-vaccine-development-to-put-patients-over-profits/
Good news, though! There's a lot that Canada can learn from the good work that's being done by others - we don't need to reinvent the wheel. Here's a thread on some of the ways we can change federal policies to achieve this: https://twitter.com/jwnickerson/status/1271108855066476544?s=20
There's also a good study that happened at the Health Committee #HESA in 2018. The report, written submissions, and testimony all gave Canada a path forward, toward open science, new models of R&D, and common-sense public health safeguards: https://www.ourcommons.ca/Committees/en/HESA/StudyActivity?studyActivityId=9929141
It's time to move ahead with a new approach to health innovation in Canada. It's clear that the model of pharmaceutical R&D that we rely on is unsustainable. There are solid policy recommendations that have been made on how to change the system, so let's do it. #LivesOverProfits
